Lifecore Biomedical, Inc.
corporate_fare Company Profile
Lifecore Biomedical, Inc. (NASDAQ:LFCR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for LFCR at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Lifecore Biomedical Lands Key Commercial Manufacturing Pact for Aesthetic Product
- Lifecore Biomedical Reports Improved Cash Flow & Legal Resolutions Amidst Adverse Internal Control Opinion & Reduced 2026 Revenue Forecast
- Lifecore Biomedical Reports Strong Q4, But Issues Significantly Lower 2026 Guidance and Discloses Major Preferred Stock Redemption Risk
- Customer Loss Expected for Lifecore Biomedical, Signaling Revenue Headwind
Financial Snapshot
Fiscal year ended May 25, 2025
Revenue
$128.87M
Net Income
-$38.72M
Diluted EPS
-$1.27
Op. Cash Flow
-$206K
Free Cash Flow
-$13.62M
Gross Profit
$40.3M
Operating Income
-$17.25M
Cash & Equivalents
$8.27M
Total Debt
$133.87M
Debt / Equity
100.20×
Net Margin
-30.0%
Shares Outstanding
37.03M sh
Source: 10-K · filed 2025-08-07 · accession 0001005286-25-000108
show_chartPrice Chart
Loading chart...
feed LFCR - Filings & News (Page 2)
LFCR
Mar 23, 2026, 7:00 AM EDT
Price at Filing:
$4.07
Real-time Price:
$6.37
Change:
+$2.30 (+57%)
Market Cap:
$242.218M
LFCR
Mar 16, 2026, 8:15 AM EDT
Price at Filing:
$6.82
Real-time Price:
$6.37
Change:
-$0.450 (-7%)
Market Cap:
$242.218M
LFCR
Mar 16, 2026, 8:08 AM EDT
Price at Filing:
$6.82
Real-time Price:
$6.37
Change:
-$0.450 (-7%)
Market Cap:
$242.218M
LFCR
Mar 16, 2026, 8:03 AM EDT
Price at Filing:
$6.82
Real-time Price:
$6.37
Change:
-$0.450 (-7%)
Market Cap:
$242.218M